Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Sara Freeman

News

Low preconception complement levels linked to adverse pregnancy outcomes in antiphospholipid syndrome

Author:
Sara Freeman
Publish date: October 12, 2021

Low levels of C3 and C4 in the 6 months prior to pregnancy were associated with several gestational and maternal complications and resulted in...

  • Read More

News

Hypoglycemia awareness program helps tricky-to-treat T1D

Author:
Sara Freeman
Publish date: October 5, 2021

New psychoeducation program tackles problematic type 1 diabetes hypoglycemia awareness, reducing severe hypoglycemia with added mental health...

  • Read More

News

Cell therapy promising as long-term limb-saving treatment in diabetes

Author:
Sara Freeman
Publish date: October 4, 2021

Fewer amputations were needed at 5 years in patients with diabetic foot and critical limb-threatening ischemia, compared with conservative...

  • Read More

News

Retinopathy risk higher in young-onset T2D, more so in men

Author:
Sara Freeman
Publish date: September 30, 2021

Gender differences in the prevalence of retinopathy have been seen in a large Norwegian population of primary care patients with type 2 diabetes...

  • Read More

News

‘Metabolically healthy obesity’ tied to substantial heart risk

Author:
Sara Freeman
Publish date: September 29, 2021

There was an increased risk for both new-onset heart failure and atrial fibrillation in people who were obese with no metabolic abnormalities.

  • Read More

News

Heart failure hospitalization risk lower with SGLT2 inhibitors than GLP-1 RAs

Author:
Sara Freeman
Publish date: September 27, 2021

SGLT2 inhibitor versus GLP-1 RA use was associated with a significantly lower rate of hospitalization for heart failure in people with diabetes....

  • Read More

News

Early vs. late TNFi switch in AS patients associated with different risk factors

Author:
Sara Freeman
Publish date: September 24, 2021

Different factors were associated with switching an initial TNF inhibitor within 2 years versus after 2 years of treatment.

  • Read More

News

Real-world data generate debate on definition of flare in axial spondyloarthritis

Author:
Sara Freeman
Publish date: September 22, 2021

Changes in the Bath Ankylosing Spondyloarthritis Disease Activity Index could be used to monitor patient-reported flares in axial...

  • Read More

News

Targeting IL-23 could still be important for axial spondyloarthritis treatment

Author:
Sara Freeman
Publish date: September 20, 2021

Results of a systematic review and meta-analysis corroborate negative trial findings for IL-23 but hint at some early benefit with risankizumab....

  • Read More

News

csDMARDs could add to TNF inhibitors’ benefits in SpA

Author:
Sara Freeman
Publish date: September 16, 2021

EuroSpA Research Collaboration data hint at better retention and remission rates with csDMARD-TNFi cotherapy versus TNFi alone in...

  • Read More

News

Biologic benefit in psoriasis might extend to arthritis prevention

Author:
Sara Freeman
Publish date: August 30, 2021

People with psoriasis had a lower risk for psoriatic arthritis if they had been treated with a biologic than if they had not, based on a study of...

  • Read More

News

Vertebral fractures still a risk with low-dose oral glucocorticoids for RA

Author:
Sara Freeman
Publish date: July 20, 2021

Vertebral, not other, osteoporotic fractures were increased in current versus past users of low-dose steroids in a retrospective cohort study.

  • Read More

News

Pharmacovigilance data implicate three new drugs in ANCA-associated vasculitis

Author:
Sara Freeman
Publish date: July 14, 2021

Mirabegron, sofosbuvir, and nintedanib join a list of 12 other drugs that have been linked to an overreporting of drug-associated ANCA vasculitis...

  • Read More

News

TNF inhibitors have delayed effect on spondyloarthritis radiographic progression

Author:
Sara Freeman
Publish date: June 11, 2021

It could take 2-4 years before plain radiographs show any sign of a benefit on the spine or sacroiliac joints.

  • Read More

News

Mavrilimumab may aid severe COVID-19 recovery

Author:
Sara Freeman
Publish date: June 10, 2021

The granulocyte/macrophage-colony stimulating factor (GM-CSF) blocker reduced the need for mechanical ventilation and death by day 29 versus...

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close